Investigación quirúrgica en urología y trasplante renal
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Capdevila J, Hernando J, Molina-Cerillo J, Plana Serrahima M, Taberna Sanz M, Castelo B, Álvarez-Escolá C, Carmona-Bayonas A, Ballester Navarro I, Iglesias L, Bover M, Garcia-Alvarez A, Lavernia J, Yayá Tur R, Ruiz S, Baste N, Lorenzo-Lorenzo I, Sanchez-Hernandez A, Sanz-Garcia E, Marquina G, Nuciforo P, Elguero B, Grande E, Alonso-Gordoa T.
Durvalumab plus tremelimumab for the treatment of patients with progressive, refractory advanced thyroid carcinoma: the phase II GETNE-DUTHY trial.
Nature Communications . 17(1): .
-
Donato S, Herrera-Martínez AD, García Sanz I, Mínguez Ojeda C, Hanzu FA, Mora M, Revuelta Sánchez-Vera R, González Boillos M, Abellán-Galiana P, Lamas C, López García MDC, Del Castillo Tous M, Ruíz Rodríguez M, Barahona San Millán R, Recasens M, Gracia Gimeno P, Robles Lazaro C, Herrero-Ruiz A, Michalopoulou T, Menéndez E, Fernández García-Salazar R, Pérez Castro P, Álvarez-Escolá C, Martín Rojas-Marcos P, García-Centeno R, González L, de Miguel Novoa P, Blanco C, Valdés N, Calatayud M, Araujo-Castro M.
Bilateral pheochromocytoma: differences in clinical and surgical outcomes with unilateral pheochromocytomas.
ENDOCRINE . 91(1): .
-
Klinglmair G, Lutz M, Telia T, van Creij NCH, Wafa H, Tymoszuk P, Heim B, Niedersuess-Beke D, Terbuch A, Subiela JD, Del Giudice F, Mayr R, Luger A, Pichler R.
Sarcopenia and recurrence risk in high-risk non-muscle-invasive bladder cancer: a nonlinear modeling approach.
Journal of Nutrition Health & Aging . 30(4): 100805-100805. Nº de citas: 1
-
Ortega Polledo LE, Sánchez Pellejero A, Bianchini Hernández GFJ, García Rico E, Redondo González E, Subiela Henríquez JD, Mata Deniz P, Marugán Álvarez MJ, Gómez Rivas J, Galante Romo I, Moreno Sierra J, Ahyai S, Miñana B, Alonso Y Gregorio S.
Prospective analysis of urinary continence and urethral stricture after Holmium laser enucleation of the prostate (HoLEP): A consecutive 254-case series.
Actas Urologicas Espanolas . 50(3): 501912-501912.
-
Baudet León J, Caño Velasco J, Polanco Pujol L, Artero Fullana S, Pastor Rodenas B, Subiela Henriquez JD, García Martín LA, Hernández Fernández C, Bielsa Carrillo A.
Current Evidence on the Use of Cystoscopy in the Follow-up of Non-Muscle-Invasive Bladder Cancer: Are We Overusing It? Systematic Review of the Literature.
ARCHIVOS ESPANOLES DE UROLOGIA . 79(3): 362-370.
-
Merelli E, Taha T, Caputo M, Obude D, Papa E, Rizzo A, Buti S, Massari F, Molina-Cerrillo J, Monteiro FSM, Maiorano BA, Santoni M.
An agent-based learning model integrating sex differences in renal cell carcinoma.
Frontiers in Immunology . 17: 1779638-1779638.
-
Mollica V, Massari F, Fujita K, Giannatempo P, Grande E, Büttner T, Bourlon MT, Taha T, Fukuokaya W, Myint ZW, Pichler R, Binz K, Molina-Cerrillo J, Kopecky J, de Liaño AG, Kucharz J, Fiala O, Matrana MR, Kopp RM, Di Civita MA, Zgura A, Ansari J, Kihnel R, De Felice F, Angel M, Monteiro FSM, Soares A, Urun Y, Buti S, Santini D, Santoni M.
Real-world effectiveness of avelumab, pembrolizumab, and enfortumab vedotin in patients with advanced urothelial carcinoma with squamous differentiation (ARON-2EV).
CANCER IMMUNOLOGY IMMUNOTHERAPY . 75(4): .
-
Ibañez Vazquez L, Pérez Romero N, Tueti Silva D, Infante S, González-Santander C, de la Parra I, Galante Romo I, Gómez Rivas JA, Moreno Sierra J.
Breaking barriers in male infertility: the power of artificial intelligence-driven solutions.
Frontiers in Urology . 6: 1719894-1719894.
-
Molina-Cerrillo J, Roviello G, Bourlon MT, Studentova H, Fiala O, Cerbone L, Kucharz J, Ansari J, Zeppellini A, Taha T, Buti S, Ürün Y, Scagliarini S, Li H, Sunela K, Park SH, Rizzo M, Zgura A, Chiari R, Seront E, Catalano M, Ghosn M, Filosa A, Soares A, Massari F, Monteiro FSM, Grande E, Porta C, Bracarda S, Santoni M.
Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)
INTERNATIONAL JOURNAL OF CANCER . 158(5): 1396-1405. Nº de citas: 1
-
Nowak E, Viëtor CL, Feelders RA, Hofland J, Araujo-Castro M, Ojeda CM, Pascual-Corrales E, Salama B, Bancos I, Sandooja R, Fassnacht M, Altieri B, Detomas M, Bobrowicz M, Ambroziak U, Gladka A, Giordano R, Bioletto F, Parasiliti-Caprino M, Torre EM, Rivas-Otero D, González-Vidal T, Ceccato F, Tizianel I, Torchio M, Palmieri S, Mangone A, Mantovani G, Chiodini I, Favero V, Prete A, Suntornlohanakul O, Morelli V, Chiodaroli M, Trofimiuk-Müldner M, Hubalewska-Dydejczyk A, Puglisi S, Reimondo G, Alexandraki KI, Spyroglou A, Falhammar H, Klosowski P, Chrisoulidou A, Tabarin A, Loli P, Angelousi A, Pignatelli D, Hanzu F, Fuld S, Pamporaki C, Athimulam S, Quinkler M, Markou A, Puar T, Deutschbein T, Hoffmann VS, Reincke M.
Effect of surgical versus conservative management on cardiovascular outcomes in patients with bilateral adrenal tumours and cortisol excess: an international, retrospective cohort study.
Lancet Diabetes & Endocrinology . 14(3): 202-215. Nº de citas: 7
-
Hevia-Palacios V, Pérez Fentes D, Vilaseca Cabo A, Jalón Monzón A, Rivero Belenchón I, Tolosa Eizaguirre E, Morales Pinto SF, Vázquez Martul D, Arrabal Polo MÁ, Gómez Dos Santos V, Cogorno Wasylkowski L, Ortiz de Urbina PI, Ballestero Diego R, Testa Sklofsky I, Fernández-Pello S.
Current management of stage T1 renal cell carcinoma in Spain: Results of a multicentre national registry.
Actas Urologicas Espanolas . 50(2): 501922-501922. Nº de citas: 2
-
van Creij NCH, Tymoszuk P, Handle F, Seeber A, Sellemond T, Martowicz A, Comperat E, Wafa H, Ormanns S, Günther M, Parson W, Noeparast M, Santer FR, Subiela JD, Grivas P, Li R, Culig Z, Pichler R.
Multi-omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapy.
Clinical and Translational Medicine . 16(3): .
-
Cerbone L, Roviello G, Calabrò F, Taha T, Grande E, Binz K, Kanesvaran R, Pirstuk A, Fiala O, Molina-Cerrillo J, Alonso-Gordoa T, Rizzo A, Pichler R, Myint ZW, Poprach A, Facchini G, Bohuslav M, Studentova H, Morelli F, Buchler T, Mennitto A, Tural D, Formisano L, Orejana I, Catalano M, Buti S, Monteiro FSM, Soares A, Gupta S, Massari F, Santoni M.
Liver metastases in advanced urothelial carcinoma (ARON-2): do pembrolizumab and avelumab make a difference in a poor-prognosis scenario?
Frontiers in Immunology . 17: 1667155-1667155.
-
Calabrò C, Ciccimarra F, Rizzo A, Cazzato G, Della Mura M, Taha T, Bourlon MT, Melichar B, Studentova H, Schieber TJ, Nardulli P, Molina-Cerrillo J, Monteiro FSM, Soares A, Massafra R, Mollica V, Massari F, Kucharz J, Santoni M.
Belzutifan monotherapy and combination therapies in renal cell carcinoma: a clinical trial perspective from the ARON working group.
EXPERT OPINION ON PHARMACOTHERAPY . 27(1): 1-11. Nº de citas: 2
-
Scilipoti P, Zaurito P, Longoni M, Tremolada G, Cosenza A, Slusarczyk A, Gabriel PE, Dutto D, Katzendorn O, Krajewski W, Laukhtina E, Oberneder K, Elena JLR, Aranda J, Puentedura AL, Velasco JC, Contieri R, Hurle R, Subiela JD, Fernández A, Marcq G, Szostek A, Mastroianni R, Simone G, Pichler R, Álvarez-Maestro M, Bazán AA, Klatte T, du Biest AM, Ferrando V, Buisan O, López AV, Zazzara M, Ludovico GM, Carando R, Radziszewski P, Soria F, Pradere B, D'Andrea D, Shariat SF, Montorsi F, Salonia A, Briganti A, Gontero P, Xylinas E, Moschini M.
Real-world outcomes of bladder-sparing strategies for BCG-unresponsive non-muscle-invasive bladder cancer: a multicenter study.
WORLD JOURNAL OF UROLOGY . 44(1): 82-82. Nº de citas: 1
-
Trilla-Fuertes L, Pedregosa-Barbas J, García-Fernández E, Zambrana F, Martínez-Salas I, Gajate P, Becerril-Gómez F, Lalanda-Delgado P, Dittmann A, López-Vacas R, Kunz L, Rubio G, Nieto-Torrero S, Pertejo A, González-Peramato P, Fresno Vara JÁ, Gámez-Pozo A, Pinto-Marín Á.
Identification of a Muscle-Invasive Bladder Carcinoma Molecular Subtype of Poor Responders to Neoadjuvant Chemotherapy and High Expression of Targetable Biomarkers.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 27(1): .
-
Artiles Medina A, Mínguez Ojeda C, Subiela JD, López Curtis D, Domínguez Gutiérrez A, Chamorro Tojeiro S, de la Parra Sánchez I, Jiménez Cidre MÁ, Gómez Dos Santos V, Burgos Revilla FJ.
A systematic review and meta-analysis evaluating the incidence, microbiological profile and risk factors associated with urinary tract infection after radical cystectomy.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS . 44(1): 12-26. Nº de citas: 1
-
Vivas D, Ferrandis R, Anguita-Sánchez M, Anguita-Gámez M, Arcelus JI, Echeverri M, Egocheaga I, Esteve-Pastor MA, Ferreiro JL, Llau JV, Roldán V, Ruiz-Nodar JM, González-Casal D, Torres-Fonseca M, López-Menéndez J, Ciria M, Leyva F, Rodríguez de Santiago E, Vidán MT, Pamplona L, Mingot-Castellano ME, Mateo-Arranz J, Polo J, Castellanos Á, Llanos C, Madridano O, Jiménez S, Freijo MDM, Puchades MJ, Lafuente J, Jiménez D, Santos-Bueso E, Ferrandis E, Figuero E, González-Nieto CJ, Castel A, Hermida JF, Marín F, Rodríguez-Padial L, Fernández-Lozano I, Hidalgo F, Cassinello C, Muñoz E, Palomo-López N.
Perioperative and periprocedural management of antithrombotic therapy: 2025 consensus document of SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT, and AEU.
REVISTA ESPANOLA DE CARDIOLOGIA . 79(1): 68-79.